New roles of calsequestrin and triadin in cardiac muscle

Por Knollmann, Björn C
Publicado em 2009

A “rough” journey to the sarcoplasmic reticulum – implications of altered calsequestrin trafficking for cardiac arrhythmia

Por Knollmann, Bjorn C.
Publicado em 2010

Power and pitfalls of using transgenic mice to optimize therapy for CPVT – a need for prospective placebo-controlled clinical trials in genetic arrhythmia disorders

Por Knollmann, Bjorn C.
Publicado em 2010

Controversies in Cardiovascular Research: Induced pluripotent stem cell-derived cardiomyocytes – boutique science or valuable arrhythmia model?

Por Knollmann, Björn C
Publicado em 2013

Cardiac regulatory mechanisms: new concepts and challenges

Por Knollmann, Björn C.
Publicado no J Physiol (2017)

Increased Myofilament Ca(2+)-Sensitivity and Arrhythmia Susceptibility

Por Huke, Sabine, Knollmann, Bjorn C.
Publicado em 2010

Genetics of Sudden Cardiac Death Syndromes

Por Chopra, Nagesh, Knollmann, Björn C.
Publicado em 2011

Oxidized CaMKII: a “heart stopper” for the sinus node?

Por Huke, Sabine, Knollmann, Björn C.
Publicado em 2011

Calsequestrin 2 and arrhythmias

Por Faggioni, Michela, Knollmann, Björn C.
Publicado em 2012

Triadin regulates cardiac muscle couplon structure and microdomain Ca(2+) signalling: a path towards ventricular arrhythmias

Por Chopra, Nagesh, Knollmann, Björn C.
Publicado em 2013

Familial Hypertrophic Cardiomyopathy – is the Frank-Starling Law kaput?

Por Huke, Sabine, Knollmann, Björn C.
Publicado em 2013

Arrhythmia Protection in Hypokalemia: A Novel Role of Ca(2+)-Activated K(+) Currents in the Ventricle

Por Faggioni, Michela, Knollmann, Bjorn C.
Publicado no Circulation (2015)

The Beat Goes On – Driven By A Cardiac Calcium Clock?

Por Raj, Satish R, Knollmann, Björn C
Publicado em 2008

EFFICACY AND POTENCY OF CLASS I ANTIARRHYTHMIC DRUGS FOR SUPPRESSION OF Ca(2+) WAVES IN PERMEABILIZED MYOCYTES LACKING CALSEQUESTRIN

Por Galimberti, Eleonora Savio, Knollmann, Bjorn C.
Publicado em 2011

Inositol 1,4,5-trisphosphate receptors (InsP(3)R) – “exciting” players in cardiac excitation-contraction coupling?

Por Roderick, H. Llewelyn, Knollmann, Björn C.
Publicado em 2013

Dantrolene: From Better Bacon to a Treatment for Ventricular Fibrillation

Por Roden, Dan M., Knollmann, Björn C.
Publicado em 2014

Calcium in atrial fibrillation — pulling the trigger or not?

Por Gomez-Hurtado, Nieves, Knollmann, Björn C.
Publicado no J Clin Invest (2014)

Channel Activity of Cardiac Ryanodine Receptors (RyR2) Determines Potency and Efficacy of Flecainide and R-Propafenone against Arrhythmogenic Calcium Waves in Ventricular Cardiomyo...

Por Savio-Galimberti, Eleonora, Knollmann, Björn C.
Publicado no PLoS One (2015)

Modelling sarcomeric cardiomyopathies in the dish: from human heart samples to iPSC cardiomyocytes

Por Eschenhagen, Thomas, Mummery, Christine, Knollmann, Bjorn C.
Publicado no Cardiovasc Res (2015)

Calsequestrin Mutations and Catecholaminergic Polymorphic Ventricular Tachycardia

Por Faggioni, Michela, Kryshtal, Dmytro O., Knollmann, Björn C.
Publicado em 2012